NIH Grants $1.9M to Oligomerix for Alzheimer's Drug Safety Studies
The **NIH** has awarded **Oligomerix, Inc.** a **$1.9 million** grant to advance safety studies for **OLX-07010**, a promising oral Alzheimer's drug. This funding paves the way for clinical trials, highlighting the government's critical support for innovative Alzheimer's research and treatment solutions.